- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 94,410 | 11.07.24 15:22:18 | +0,870 | +0,93% | 94,410 | 94,470 | 94,100 | 93,540 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 982,400 | 11.07.24 13:09:28 | +11,800 | +1,22% | 978,400 | 988,200 | 982,400 | 970,600 |
